Choroidal drainage good option for acute angle closure

Article

Choroidal drainage can be a safe and effective interventional procedure for patients presenting with acute angle closure secondary to Topiramate toxicity.

Choroidal drainage can be a safe and effective interventional procedure for patients presenting with acute angle closure secondary to Topiramate toxicity, according to a case report published in the December 2007 issue of the Journal of Glaucoma.

Topiramate is an anti-convulsant drug administered to treat certain types of seizures in patients with epilepsy.

Rajul Parikh and co-workers from the Christian Medical College, Vellore and the LV Prasad Eye Institute, Hyderabad, India reported the role of choroidal drainage in a patient with acute bilateral angle closure secondary to cilio-choroidal effusion with Topiramate.

Two-weeks after commencing Topiramate for the management of epilepsy, the patient developed acute bilateral angle closure secondary to cilio-choroidal effusion with lenticulo-corneal touches for which choroidal drainage was performed.

Following the procedure, the anterior chamber deepened, the corneal oedema resolved, choroidals began to resolve and intraocular pressure was controlled without medication. The researchers therefore concluded that, in patients presenting with acute angle closure secondary to Topiramate toxicity, choroidal drainage is a safe and effective interventional procedure.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.